We detected multiple genomic HBV integrations in two distinct types of liver cancer, with recurrent events at TERT, ZMAT4, MET, ANKFN1, PLXNB2 in ICC, and TERT, ALKBH5 in CHC. This evidence concerns the gene ANKFN1 and liver cancer.